Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy.
Landau
A
A
Service d'Hépatologie et de Gastro-Entérologie, Hôpital Européen Georges Pompidou, Université Pierre et Marie Curie, Paris, France.
Batisse
D
D
Piketty
C
C
Jian
R
R
Kazatchkine
M D
MD
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology / Q000627:therapeutic use*; D009705:Nucleosides / Q000494:pharmacology / Q000627:therapeutic use*; D012254:Ribavirin / Q000494:pharmacology / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D009705:Nucleosides; D012254:Ribavirin